BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 30900046)

  • 1. Sensitizing of β-lactam resistance by tannic acid in methicillin-resistant S. aureus.
    Kırmusaoğlu S
    World J Microbiol Biotechnol; 2019 Mar; 35(4):57. PubMed ID: 30900046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved β-Lactam Susceptibility Against ica-Dependent Biofilm-Embedded Staphylococcus aureus by 2-Aminothiazole.
    Kirmusaoglu S
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
    Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
    J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
    Hu Y; Liu A; Vaudrey J; Vaiciunaite B; Moigboi C; McTavish SM; Kearns A; Coates A
    PLoS One; 2015; 10(2):e0117664. PubMed ID: 25692771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
    Banerjee R; Fernandez MG; Enthaler N; Graml C; Greenwood-Quaintance KE; Patel R
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):827-33. PubMed ID: 23340864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Antibacterial Activity Between 1,4-Naphthoquinone and β-Lactam Antibiotics Against Methicillin-Resistant
    Yap JKY; Tan SYY; Tang SQ; Thien VK; Chan EWL
    Microb Drug Resist; 2021 Feb; 27(2):234-240. PubMed ID: 32589487
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic Anti-bacterial Effects of Phellinus baumii Ethyl Acetate Extracts and β-Lactam Antimicrobial Agents Against Methicillin-Resistant Staphylococcus aureus.
    Hong SB; Rhee MH; Yun BS; Lim YH; Song HG; Shin KS
    Ann Lab Med; 2016 Mar; 36(2):111-6. PubMed ID: 26709257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
    Sharma AD; Gutheil WG
    Microbiol Spectr; 2023 Feb; 11(1):e0372622. PubMed ID: 36519895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
    Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
    Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
    Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antibacterial effect of apigenin with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus.
    Akilandeswari K; Ruckmani K
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):74-82. PubMed ID: 28145860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triterpenoid saponin from
    Tsutamoto S; Iwasaki Y; Shinohara A; Imamiya R; Samukawa K; Kawada-Matsuo M; Komatsuzawa H; Yamada Y; Mandokoro K; Iwao H; Horiguchi Y; Osada-Oka M
    Microbiol Spectr; 2024 Jun; 12(6):e0322723. PubMed ID: 38647286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in
    Lai L-Y; Satishkumar N; Cardozo S; Hemmadi V; Marques LB; Huang L; Filipe SR; Pinho MG; Chambers HF; Chatterjee SS
    mBio; 2024 May; 15(5):e0288923. PubMed ID: 38530033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of ampicillin and a bioactive fraction from Duabanga grandiflora.
    Santiago C; Pang EL; Lim KH; Loh HS; Ting KN
    BMC Complement Altern Med; 2015 Jun; 15():178. PubMed ID: 26060128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
    Therien AG; Huber JL; Wilson KE; Beaulieu P; Caron A; Claveau D; Deschamps K; Donald RG; Galgoci AM; Gallant M; Gu X; Kevin NJ; Lafleur J; Leavitt PS; Lebeau-Jacob C; Lee SS; Lin MM; Michels AA; Ogawa AM; Painter RE; Parish CA; Park YW; Benton-Perdomo L; Petcu M; Phillips JW; Powles MA; Skorey KI; Tam J; Tan CM; Young K; Wong S; Waddell ST; Miesel L
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4662-70. PubMed ID: 22710113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro Potential Effect of Morin in the Combination with β-Lactam Antibiotics Against Methicillin-Resistant Staphylococcus aureus.
    Mun SH; Lee YS; Han SH; Lee SW; Cha SW; Kim SB; Seo YS; Kong R; Kang DH; Shin DW; Kang OH; Kwon DY
    Foodborne Pathog Dis; 2015 Jun; 12(6):545-50. PubMed ID: 26067230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial and synergic effects of gallic acid-grafted-chitosan with β-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
    Lee DS; Eom SH; Kim YM; Kim HS; Yim MJ; Lee SH; Kim DH; Je JY
    Can J Microbiol; 2014 Oct; 60(10):629-38. PubMed ID: 25216286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
    Foster TJ
    Trends Microbiol; 2019 Jan; 27(1):26-38. PubMed ID: 30031590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Lactam Antibiotics Enhance the Pathogenicity of Methicillin-Resistant Staphylococcus aureus via SarA-Controlled Lipoprotein-Like Cluster Expression.
    Shang W; Rao Y; Zheng Y; Yang Y; Hu Q; Hu Z; Yuan J; Peng H; Xiong K; Tan L; Li S; Zhu J; Li M; Hu X; Mao X; Rao X
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.